The PE ratio for LivaNova stock stands at 36.39 as of Jun 3, 2026. This is based on the current EPS of $1.96 and the stock price of $71.33 per share.
Over the last nine years, the average PE ratio of LivaNova has been 224.65. The current 36.39 PE ratio is 84% below the historical average. Over the past nine years, LIVN's PE ratio was at its highest in the Sep 2023 quarter at 1,057.6, with a price of $52.88 and an EPS of $0.05. The Mar 2026 quarter recorded the bottom point at 32.43, with a price of $63.56 and an EPS of $1.96.
Maximum annual decrease: -74.76% in 2024
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2025 | N/A | N/A | $61.53 | -$4.45 |
| 2024 | 39.58 | -74.76% | $46.31 | $1.17 |
| 2023 | 156.79 | N/A | $51.74 | $0.33 |
| 2022 | N/A | N/A | $55.54 | -$1.61 |
| 2021 | N/A | N/A | $87.43 | -$2.68 |
| 2020 | N/A | N/A | $66.21 | -$7.18 |
| 2019 | N/A | N/A | $75.43 | -$3.26 |
| 2018 | N/A | N/A | $91.47 | -$3.91 |
| 2017 | N/A | N/A | $79.92 | -$0.52 |
| 2016 | N/A | N/A | $44.97 | -$1.29 |
| 2015 | N/A | N/A | N/A | $2.19 |
| 2014 | N/A | N/A | N/A | $2.02 |
| 2013 | N/A | N/A | N/A | $1.68 |
| 2012 | N/A | N/A | N/A | $0.04 |
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Mar 2026 | 32.43 | N/A | $63.56 | $1.96 |
| Dec 2025 | N/A | N/A | $61.53 | -$4.45 |
| Sep 2025 | N/A | N/A | $52.38 | -$3.99 |
| Jun 2025 | N/A | N/A | $45.02 | -$3.87 |
| Mar 2025 | N/A | N/A | $39.28 | -$4.07 |
| Dec 2024 | 39.58 | -66.85% | $46.31 | $1.17 |
| Sep 2024 | 119.41 | N/A | $52.54 | $0.44 |
| Jun 2024 | N/A | N/A | $54.82 | -$0.31 |
| Mar 2024 | N/A | N/A | $55.94 | -$0.59 |
| Dec 2023 | 156.79 | -85.17% | $51.74 | $0.33 |
| Sep 2023 | 1,057.6 | N/A | $52.88 | $0.05 |
| Jun 2023 | N/A | N/A | $51.43 | -$1.82 |
| Mar 2023 | N/A | N/A | $43.58 | -$1.53 |
| Dec 2022 | N/A | N/A | $55.54 | -$1.61 |
| Sep 2022 | N/A | N/A | $50.77 | -$1.69 |
The Historical Valuation Regime chart shows where the stock's current valuation sits relative to its own historical valuation range over the selected lookback period.
This is a history-relative tool, not a market-relative percentile. It does not compare the stock to other companies. Instead, it compares each historical valuation reading to the stock's own past readings.
The threshold lines are calculated them from the stock's real historical values using percentile interpolation. That is why some colored bands are narrow while others are wide: the band widths reflect how the stock actually traded through time.
| Historical percentile | Regime | Chart meaning |
|---|---|---|
| 0-10 | Historically Low | Deep cheap zone |
| >10-25 | Below Average | Cheap relative to history |
| >25-75 | Average | Within the normal historical range |
| >75-90 | Above Average | Expensive relative to history |
| >90-100 | Historically High | Extreme or stretched valuation |
| Chart element | What it tells you |
|---|---|
| Main line | The actual historical valuation values over time for the selected metric. |
| Dashed horizontal lines | The stock's computed P10, P25, Median, P75, and P90 thresholds for the selected period. |
| Colored bands | The historical valuation zones between those thresholds. |
| Metric boxes | Current ratio, historical median, current percentile, and current regime. |
| Timeline strip | A condensed regime history showing how the stock moved between cheap, fair, and expensive states across each observation. |
Current Percentile is the percentile rank of the latest valid historical observation within the selected lookback range.
Current Regime is assigned directly from the latest observation's percentile bucket using the fixed 10 / 25 / 75 / 90 cutoffs shown above.
This chart is most useful for answering a narrow question: Is this stock trading high, low, or normal relative to its own history? It works best alongside growth, profitability, and forward-looking business analysis, because a stock can deserve a higher or lower regime if its business quality has changed.
The current PE ratio of LIVN is below the 3, 5 and 10-year averages.
With a P/E of 36.39, LIVN is above the Healthcare sector and the industry average. Compared to its Healthcare sector average of 23.02, LivaNova's P/E is 58% higher.
| Stock name | PE ratio | Market cap |
|---|---|---|
| LIVN LivaNova PLC | 37.62 | $4.05B |
| OFIX Orthofix Medical Inc | N/A | $416.75M |
LIVN's price to earnings ratio is 36.39 as of Jun 3, 2026.
The 3-year average PE ratio for LIVN stock is 281.16.
The 5-year average PE ratio for LIVN stock is 281.16.
In the last nine years, the Sep 2023 quarter recorded the highest quarterly PE ratio at 1,057.6.
LIVN's current price to earnings ratio is 84% below its 9-year historical average.
You can calculate the PE ratio by dividing the most recent stock price by the trailing twelve months EPS. As of today (Jun 3, 2026), LivaNova's stock price is $71.33. The earnings per share for the trailing twelve months (TTM) ending Mar 2026 is $1.96. Therefore, LivaNova's P/E ratio for today is 36.39. PE RATIO(36.39) = STOCK PRICE($71.33) / TTM EPS($1.96)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.